Patient Preferences With Pharmaceutical Care: In-person Versus Digital Health

Sponsor

Lebanese University (Other)

Overall Status

Recruiting

CT.gov ID

NCT05999279

Collaborator

(none)

386

Enrollment

Locations

Anticipated Duration (Months)

193

Patients Per Site

64.6

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Digital pharmaceutical care, also known as e-pharmaceutical care or telepharmacy, refers to using digital technologies to provide remote pharmaceutical care services. It involves the application of digital tools and platforms to deliver medication-related services, patient counseling, medication management, and other pharmaceutical care activities. It allows patients to access pharmaceutical services conveniently from their homes or any location with an internet connection. This is particularly beneficial for individuals with limited mobility, those living in rural or underserved areas, or patients with difficulty visiting a physical pharmacy. However, it is essential to note that while digital pharmaceutical care provides many benefits, it may only suit some patients or situations. Some individuals may still prefer face-to-face interactions or may require hands-on assistance, especially for complex medication management. Healthcare providers should assess the appropriateness of digital solutions on a case-by-case basis and ensure patient privacy and data security when implementing digital pharmaceutical care services.

Condition or Disease	Intervention/Treatment	Phase
Patient Preference	Behavioral: Survey

Study Design

Study Type:

Observational

Anticipated Enrollment :

386 participants

Observational Model:

Ecologic or Community

Time Perspective:

Cross-Sectional

Official Title:

A Cross-sectional Study Addressing Lebanese Patient Preferences With Pharmaceutical Care: Traditional Versus Digital Health?

Actual Study Start Date :

Jul 1, 2023

Anticipated Primary Completion Date :

Aug 31, 2023

Anticipated Study Completion Date :

Sep 30, 2023

Arms and Interventions

Arm	Intervention/Treatment
Patient Convenient sampling of patients who took at least one medication in the past month	Behavioral: Survey Developed questionnaire to assess the literacy of patients + another survey to assess their preferences regarding traditional versus digital pharmaceutical care

Arm

Intervention/Treatment

Patient

Convenient sampling of patients who took at least one medication in the past month

Behavioral: Survey

Developed questionnaire to assess the literacy of patients + another survey to assess their preferences regarding traditional versus digital pharmaceutical care

Outcome Measures

Primary Outcome Measures

Patient preference [through study completion, an average of 2 months]
A self-reported questionnaire was developed and piloted on the first 30 patients visiting the pharmacies. Minor modifications were performed taking into consideration two expert reviews. It is available in Arabic (native language) and English based on participants' preferences. It includes 3 parts: the first part comprises the baseline characteristics of the patients and their medical history/habits; the second part reports patients' preferences, benefits and disadvantages of each of the outcomes (in-person versus digital health); and the third part assess e-literacy among them using the e-HEALS 8-item scale previously validated on the Arab population.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 75 Years

Sexes Eligible for Study:

All

Inclusion Criteria:

Patients who took at least one medication in the past month
Patient visiting two community pharmacies

Exclusion Criteria:

Those refusing to participate
Those with severe hearing or mental problems

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Pharmacy Bouchi	Beirut	Mount Lebanon	Lebanon	0000
2	Pharmacy du Liban	Beirut		Lebanon	0000

Sponsors and Collaborators

Lebanese University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Georges Hatem, Primary investigator, Lebanese University

ClinicalTrials.gov Identifier:

NCT05999279

Other Study ID Numbers:

12/23/D

First Posted:

Aug 21, 2023

Last Update Posted:

Aug 21, 2023

Last Verified:

Aug 1, 2023

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Georges Hatem, Primary investigator, Lebanese University

pharmaceutical care

preference

digital care

Study Results

No Results Posted as of Aug 21, 2023